We are observing increased variability in the performance of SMRTcells by lot, strip and within a strip. Using the same SMRTbell template on different sequencing runs the variability can be as much as a two fold difference between strips of SMRTcells. We would like advice from other users who may experiencing the same issue.
Unconfigured Ad
Collapse
X
-
Within a week, with the same SMRTbell template and loading concentration went from 47.44% P1 to 26.64% P1. Accuracy dipped from 0.841 to 0.831. Polymerase read length N50 had a smaller drop from 16285 to 15849.Originally posted by ECO View PostAre you referring to just successful loading? Or some other metrics (RL, accuracy)?
Comment
-
-
Occasionally we see this occur and it was time to put it out to the community. We typically do a titration of SMRTbell concentration for loading and then do a production run on a strip of SMRTcells. There will be periods of time when the tritration and production runs are very consistent and then there are other times when they are not consistent and even not consistent within a strip of SMRTcells.Originally posted by GenoMax View Post@ribodoc: Was there a time when you were regularly getting consistent results and now you are not?
Comment
-
-
That has been more or less the story. While I don't work at the bench I hear similar observations most of the time. There is no logical explanation that can be put forth either. Hopefully Sequel will be more reliable.Originally posted by ribodoc View PostOccasionally we see this occur and it was time to put it out to the community. We typically do a titration of SMRTbell concentration for loading and then do a production run on a strip of SMRTcells. There will be periods of time when the tritration and production runs are very consistent and then there are other times when they are not consistent and even not consistent within a strip of SMRTcells.
Comment
-
-
-
@Genomax...the logical explanation is that the SMRTcell production process is dramatically more complicated than all other sequencing consumables, ZMW size and uniformity, the micromirror shape, aluminum coating, then on top of that the blocking of the surface and then the biotinylation.
I know it's no solace to scientists trying to do reproducible production (we run two RSII's all the time), but it's kind of amazing just how well it all works, and is a testament to all the people that have contributed at PACB. (disclaimer I worked there for a long time and know a lot of people there still)
Comment
-
-
I have nothing but admiration for the amount of technology that went into making the original PacBio machine, consumables.
Based on anecdotal references keeping an RSII running ALL the time seems to be essential for its well being. Sadly we could not do that.
Comment
-
-
The SMRT-cell quality (and correlated to it the yields) can indeed be quite variable in general .
The very last batches of SMRT-cells seem to be more variable than usual (for us and also some other labs). These higher frequency problems seem to occur at least once a year.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
Today, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 11:10 AM
|
0 responses
8 views
0 reactions
|
Last Post
by SEQadmin2
Today, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
30 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
38 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
Comment